Compare Align Technology, Inc. (ALGN) vs Infosys Limited (INFY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Infosys Limited — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Infosys Limited trades at $11.19 (market cap $45.83B). The key difference: Infosys Limited is far larger — about 3.6× Align Technology, Inc.'s market cap, and Infosys Limited pays a 4.79% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | INFY | |
|---|---|---|
Market Cap | $12.86B | $45.83B |
Sector | Health | Technology |
52-Week High | $207.19 | $20.22 |
52-Week Low | $124.88 | $10.49 |
Enterprise Value | $11.92B | $43.05B |
Dividend Yield | — | 4.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
INFY trades at $10.94, down 1.71% for the day, with technical indicators showing a bearish trend. The company maintains strong profitability with 16.44% net margins and 31.57% ROE, though recent earnings show mixed results with one miss and two beats. Recent news highlights INFY's aggressive AI partnerships across healthcare, banking, and media sectors, positioning the company for digital transformation leadership.
The stock presents a valuation opportunity with P/E of 13.68 below industry averages, supported by analyst consensus target of $12.14 (11% upside). Key risks include competitive pressures in IT services and potential margin compression from AI investments. Current institutional sentiment leans neutral with 52.5% hold ratings amid transitional business focus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
